Hooman Madyoon, MD
Cardiology · Los Angeles, CANPI 1285696476
Payments from drug & device makers
Across 619 payments — averaging $38.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$5K
- Boston Scientific$3K
- Terumo Medical Corporation$2K
- Novartis$2K
- Abbott$967
- Esperion Therapeutics, Inc.$810
- plus $10K from 51 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$23,620 in reported general payments places this provider in the 90th percentile of 156 cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiology in Los Angeles
- Sanjay KaulLos Angeles$1.1M
- Jamshid MaddahiLos Angeles$147K
- Andrew KimLos Angeles$5K
- Shawn ShahLos Angeles$3K
- Mark UrmanLos Angeles$1K
- Hiram PalmerLos Angeles$979
- Rene PackardLos Angeles$774
- Norman LeporBeverly Hills$7.1M
- Mahmoud Eslami-FarsaniSanta Ana$410K
- Anil ShahSanta Ana$372K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.